Can-Am Care announces click-on pen needles available to all U.S. pharmacies
ATLANTA A company that makes branded and store-brand diabetes care products has expanded the national distribution of a line of click-on pen needles.
Can-Am Care announced this week that its Clickfine pen needles are available to all pharmacies in the United States through drug wholesalers AmerisourceBergen, Cardinal, McKesson and H.D. Smith.
The needles are also available at such chains as Publix, Kroger stores, Discount Drug Mart and Food City. Walmart sells them under its ReliOn brand, and they’re sold at Good Neighbor Pharmacy’s more than 2,700 independent retail pharmacies under the Good Neighbor Pharmacy Clickfine Pen Needles brand.
The pen needles are compatible with major brands of insulin pens, such as Sanofi-Aventis’ Solostar, Novo Nordisk’s Flexpen and Eli Lilly & Co.’s Kwikpen, as well as other such injection pens as Lilly’s and Amylin Pharmaceuticals’ Byetta and Amylin’s SymlinPen.
“With distribution now through the major drug wholesalers, more and more people with diabetes now have access to the one pen needle that’s fast, easy and simple to attach with just a ‘clock’ instead of traditional twists and turns — and the cost is substantially less than the leading pen needle brand,” said Julie Arel, Can-Am Care marketing manager for insulin delivery.
Johnson & Johnson unveils large drug development pipeline
NEW BRUNSWICK, N.J. Drug maker Johnson & Johnson boasted a large drug development pipeline in a statement preceding a meeting with investors Thursday.
The company highlighted early-stage compounds and new regulatory filings in neuroscience, cardiovascular disease, immunology, infectious diseases and cancer, as well as new uses for drugs already on the market.
The company also mentioned the launches of the arthritis and psoriasis drug Simponi (golimumab) and the painkiller Nucynta (tapentadol) and a focus on growing core products like the inflammatory disorder drug Remicade (infliximab), the antipsychotic Risperdal Consta (risperidone) and the attention deficit hyperactivity disorder drug Concerta (methylphenidate hydrochloride).
“We are very optimistic about our future in pharmaceuticals,” J&J worldwide chairwoman of pharmaceuticals Sheri McCoy said in a statement. “We are well-positioned with an industry-leading pipeline, the global reach and financial resources of Johnson & Johnson, a long, rich history in pharmaceuticals and a broad portfolio that is grounded in science and addresses serious unmet needs.”
Albertsons selects PDX to provide pharmacy technology solution
FORT WORTH, Texas Albertsons has selected PDX and affiliates Rx.com and NHIN to provide its pharmacy technology solution, replacing its current system with the new Enterprise Pharmacy System.
The chain’s pharmacies will implement the Rx.com Electronic Pharmacy Record, which facilitates chainwide DUR checking and allows patients the convenience of shopping at any Albertsons LLC pharmacy. In addition, NHIN will provide complete submissions, reconciliations and collections services for the retailer, as well as manage its day-to-day central host operations via Host Administrative Services.
The company plans to pilot EPS in pharmacies in Texas and Arizona later this year, and will roll out the technology companywide in 2010. Albertsons LLC currently operates nearly 250 stores in Arizona, Arkansas, Colorado, Florida, Louisiana, New Mexico and Texas.